Ottawa-based medical isotope maker Nordion Inc. (TSX: NDN; NYSE: NDZ) says it expects an “important” ruling in less than two weeks that could end a four-year dispute between the company and the federal government. Ottawa Business Journal
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.